The Eurozone economy grew 0.3% in Q4 2025, matching the previous quarter's pace and easing earlier recession fears. However, analysts warn that the euro's sharp 14.4% gain against the dollar over the past year threatens to undermine the competitiveness of European exports.
Iran has announced plans to designate the armed forces of European Union member states as terrorist organizations, a direct response to the EU's blacklisting of the Islamic Revolutionary Guard Corps. The escalation marks a new low in diplomatic relations and raises fears of further regional instability.
As the EU's landmark 'Next Generation' fund nears its final payout deadlines, its ambitious goal of modernizing the bloc's economy is being hampered by bureaucracy, skills gaps, and questions over long-term sustainability, despite pockets of innovation.
As geopolitical tensions and trade concerns weigh on sentiment, a screen of European equities uncovers potential value opportunities, with some companies trading at discounts of nearly 50% to their estimated intrinsic value.
The European Union has taken the unprecedented step of designating Iran's Islamic Revolutionary Guard Corps as a terrorist entity, triggering a sharp diplomatic crisis. Iran has denounced the move as illegal and politically motivated, vowing to respond.
As European indices face headwinds, a select group of small-cap companies are seeing executives put their own money on the line. We examine three firms where insider buying signals conviction amidst broader uncertainty.
As the STOXX Europe 600 stumbles under geopolitical and trade pressures, a focus on companies with significant insider ownership reveals where leadership is putting its own capital on the line. We examine three firms where high insider stakes coincide with robust growth forecasts.
Major European neobanks like Revolut, Monzo, and bunq are renewing their push for a U.S. banking license, betting on regulatory shifts and market potential. Yet, the path is fraught with complexity, geopolitical uncertainty, and fierce competition.
The Supreme Court of British Columbia has granted final approval for Coeur Mining's acquisition of New Gold, moving the deal into its final regulatory phase. The transaction, poised to significantly expand Coeur's precious metals footprint, advances as the miner's stock shows considerable strength over the past year.
After a decade of development and multiple clinical setbacks, Sanofi's venglustat has met its primary goal in a Phase 3 trial for Type 3 Gaucher disease, offering new hope for neurological symptoms. The drug, however, failed a separate late-stage study for Fabry disease.
Beijing has lowered punitive tariffs on key EU dairy products, offering some relief to exporters like Arla and Lactalis. While welcomed as a de-escalation, European trade bodies argue the remaining duties are unjustified and call for continued negotiations to resolve the trade dispute.
Despite crypto market turmoil and mounting unrealized losses, BitMine Immersion Technologies made its largest weekly Ethereum purchase of the year, as Chairman Tom Lee points to a divergence between price action and robust on-chain activity.
Bishkek moves to engage Brussels after reports emerge that the EU is preparing to deploy its new anti-circumvention tool, targeting Kyrgyzstan's role as a conduit for goods to sanctioned Russia.
A damning report from the EU's financial watchdog reveals the bloc's struggle to secure the minerals essential for its climate goals, highlighting failed trade deals, stalled recycling, and persistent over-reliance on external suppliers.
Despite sitting on over $6 billion in unrealized losses, publicly-listed crypto firm BitMine Immersion Technologies continues its aggressive accumulation of Ethereum, viewing the price slump as a strategic buying opportunity.
The CoinDesk 20 Index, a key benchmark for the digital asset market, fell sharply over the weekend, with every constituent in the red. Ethereum's 13.9% drop was a primary driver of the downturn.
A damning report from the European Court of Auditors reveals the bloc is falling dangerously behind in securing the lithium, cobalt, and nickel needed for its energy transition, leaving climate goals and strategic autonomy in jeopardy.
Prominent crypto analyst Tom Lee faces a wave of skepticism after his aggressive price predictions for Ethereum and Bitcoin fail to materialize amid a market downturn, sparking debate over the role of high-profile forecasts in volatile markets.
Tesla's sales decline in Europe continues despite new lower-cost models, while industry buzz swirls around a hotly denied report of potential Ford-Xiaomi collaboration. Meanwhile, U.S. dealers show surprising pragmatism toward the EV transition.
Analyst Piper Sandler has lowered its price target on Black Diamond Therapeutics (BDTX) while maintaining an Overweight rating, following a broad review of its biotech coverage. The adjustment comes even as the company recently reported encouraging Phase 2 data for its lead oncology drug candidate.
